Detalhe da pesquisa
1.
Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease.
J Biol Chem
; 293(26): 10026-10040, 2018 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29739850
2.
Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function.
Proc Natl Acad Sci U S A
; 107(39): 16952-7, 2010 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20837538
3.
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.
Front Neurol
; 14: 1112207, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37082446
4.
Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia.
Cancer
; 118(13): 3433-45, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22139798
5.
Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors.
J Biomed Biotechnol
; 2011: 514261, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21765634
6.
Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
Cancer Chemother Pharmacol
; 81(3): 483-495, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313067
7.
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.
Neuro Oncol
; 17(11): 1463-73, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795306
8.
Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia.
PLoS One
; 7(12): e51611, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23284724
9.
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
Neuro Oncol
; 13(8): 894-903, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653597